Wells Fargo Upgrades Travere Therapeutics (TVTX) to Overweight

October 21, 2024 5:38 AM EDT Send to a Friend
(Updated - October 21, 2024 6:42 AM EDT)

Wells Fargo analyst Mohit Bansal upgraded Travere Therapeutics (NASDAQ: TVTX) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login